Clinical trial landscape for stem cells in autoimmune and inflammatory diseases: a comprehensive analysis and path forward

Stem cell-based therapies demonstrate significant therapeutic potential for autoimmune and inflammatory diseases. To accelerate clinical translation, the field must address standardization challenges, enhance late-phase trial development, and establish robust regulatory frameworks. These efforts are essential for realizing the full therapeutic potential of stem cell therapies.